Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2560
Abstract: This study aimed to evaluate the effect of dapagliflozin on 1 and 3‐month maximal functional capacity in patients with stable heart failure with reduced ejection fraction (HFrEF). read more here.
Keywords: heart failure; maximal functional; failure reduced; functional capacity ... See more keywords